News Daily News Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data Michael O'Riordan July 14, 2020
News Daily News Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects Michael O'Riordan July 13, 2020
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Daily News Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19 Michael O'Riordan June 08, 2020
News Daily News Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans Michael O'Riordan May 15, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI Michael O'Riordan April 17, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years Michael O'Riordan March 30, 2020
News Conference News ACC 2020 More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA Michael O'Riordan March 28, 2020
News Daily News Who Should Head to the Cath Lab in the COVID-19 Pandemic? Michael O'Riordan March 26, 2020
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Conference News CRT 2020 PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE Michael O'Riordan February 25, 2020
News Daily News Acute MI Symptom Clustering Differs in Men and Women: VIRGO Michael O'Riordan February 21, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019